Skip to content

Evaluation of a Tailored Virtual Intervention to Empower Persons Living With HIV for Therapy Self-management

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01510340
Acronym
HIVMediconline
Enrollment
217
Registered
2012-01-16
Start date
2012-01-31
Completion date
2020-06-30
Last updated
2021-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

adherence, HIV, antiretroviral therapy, tailored web intervention

Brief summary

The purpose of this study is to evaluate the efficacy of an online virtual intervention in optimizing adherence to antiretroviral medication intake among Persons Living with HIV (PLHIV).

Interventions

BEHAVIORALVIH-TAVIE

The tailored virtual intervention is composed of four interactive computer sessions hosted by a virtual nurse who engages the PLHIV in a medication-intake self-management skills-learning process.

Sponsors

Fonds de la Recherche en Santé du Québec
CollaboratorOTHER_GOV
Centre hospitalier de l'Université de Montréal (CHUM)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* have to be under ART for at least six months¸ * have internet access

Exclusion criteria

* be pregnant * active IV drug user * actual diagnosis of psychiatric health problem

Design outcomes

Primary

MeasureTime frameDescription
Adherence6 monthsAdherence will be evaluated through a self-administered questionnaire that was developed for and validated on the targeted population (Godin, Gagné, & Naccache, 2003). The questionnaire comprises seven items that serve to determine how many times a person forgets to take his or her medication. The questionnaire's validity was demonstrated (sensitivity: 71 %; specificity: 72%; correct classification: 72%; odds ratio: 6.15) using immunologic (CD4 count) and virologic (viral load) parameters as validation criteria. Adherence is defined as the intake of at least 95% of prescribed tablets.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026